2DE Stock Chart & Stats
€0.18
€0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range€0.18 - €7.10
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
€5.13M
Enterprise Value-€17.26M
Total Cash (Recent Filing)€18.05M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.29
Shares Outstanding10,927,213
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.21
Price to Sales (P/S)0.00
P/FCF Ratio-0.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-49.01
Revenue Forecast (FY)N/A
Genprex News
2DE FAQ
What was Genprex’s price range in the past 12 months?
Genprex lowest stock price was €0.18 and its highest was €7.09 in the past 12 months.
What is Genprex’s market cap?
Genprex’s market cap is €5.13M.
When is Genprex’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genprex’s earnings last quarter?
Currently, no data Available
Is Genprex overvalued?
According to Wall Street analysts Genprex’s price is currently Undervalued.
Does Genprex pay dividends?
Genprex does not currently pay dividends.
What is Genprex’s EPS estimate?
Genprex’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genprex have?
Genprex has 10,927,213 shares outstanding.
What happened to Genprex’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genprex?
Currently, no hedge funds are holding shares in DE:2DE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genprex
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
Technical Analysis
Options Prices
Currently, No data available
---